Cite
Immunohistochemical CD271 expression correlates with melanoma progress in a case-control study.
MLA
Nielsen, Patricia Switten, et al. “Immunohistochemical CD271 Expression Correlates with Melanoma Progress in a Case-Control Study.” Pathology, vol. 50, no. 4, June 2018, pp. 402–10. EBSCOhost, https://doi.org/10.1016/j.pathol.2017.12.340.
APA
Nielsen, P. S., Riber-Hansen, R., & Steiniche, T. (2018). Immunohistochemical CD271 expression correlates with melanoma progress in a case-control study. Pathology, 50(4), 402–410. https://doi.org/10.1016/j.pathol.2017.12.340
Chicago
Nielsen, Patricia Switten, Rikke Riber-Hansen, and Torben Steiniche. 2018. “Immunohistochemical CD271 Expression Correlates with Melanoma Progress in a Case-Control Study.” Pathology 50 (4): 402–10. doi:10.1016/j.pathol.2017.12.340.